Analysis shines new light on weight-loss drug use | REUTERS

Only one in four US patients prescribed Novo Nordisk’s Wegovy or Ozempic for weight loss were still taking the popular medications two years later, according to an analysis of US pharmacy claims that also showed a steady decline in use over time. #News #wegovy #ozempic #weightloss #usa #health #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow Reuters on Instagram: